Troubles with tuberculosis prevention

New England Journal of Medicine

Volumn 370, Issue 4, 2014, Pages 375-376

  Rubin, Eric J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEDAQUILINE; ISONIAZID; RIFAPENTINE;

ANTIBIOTIC RESISTANCE; BACTERIAL LOAD; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; DISEASE CONTROL; DISEASE COURSE; DISEASE TRANSMISSION; EDITORIAL; HUMAN; INTERVENTION STUDY; LATENT TUBERCULOSIS; MEDICATION COMPLIANCE; MONOTHERAPY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RISK REDUCTION; SECONDARY PROPHYLAXIS; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE; TUBERCULOSIS;

EID: 84892730452     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1312301     Document Type: Editorial

References (6)

1. Churchyard GJ, Fielding KL, Lewis JJ, et al. A trial of mass isoniazid preventive therapy for tuberculosis control. N Engl J Med 2014;370:301-10.
2. Comstock GW, Ferebee SH, Hammes LM. A controlled trial of community-wide isoniazid prophylaxis in Alaska. Am Rev Respir Dis 1967;95:935-43.
3. WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders. Geneva: World Health Organization, 2012.
4. Ayles H, Muyoyeta M, Du Toit E, et al. Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial. Lancet 2013;382:1183-94.
5. Sterling TR, Villarino ME, Borisov AS, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011;365:2155-66.
6. Koul A, Vranckx L, Dendouga N, et al. Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis. J Biol Chem 2008;283:25273-80.